Yaron Werber
Stock Analyst at TD Cowen
(4.93)
# 192
Out of 5,065 analysts
777
Total ratings
55.8%
Success rate
25%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Reiterated: Buy | $60 | $24.17 | +148.24% | 22 | Oct 13, 2026 | |
| ALEC Alector | Reiterated: Hold | n/a | $1.84 | - | 26 | Oct 5, 2026 | |
| GMAB Genmab | Reiterated: Buy | $43 | $37.00 | +16.22% | 27 | Oct 5, 2026 | |
| FHTX Foghorn Therapeutics | Downgraded: Hold | n/a | $1.86 | - | 16 | Oct 1, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $57 | $11.25 | +406.67% | 6 | Sep 29, 2026 | |
| ZYME Zymeworks | Initiated Coverage: Buy | $34 | $25.03 | +35.84% | 6 | Sep 29, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $84 | $42.94 | +95.62% | 47 | Sep 23, 2026 | |
| AMGN Amgen | Reiterated: Buy | $452 | $432.49 | +4.51% | 75 | Sep 22, 2026 | |
| ROIV Roivant Sciences | Rated: Buy | $50 → $55 | $33.53 | +64.03% | 27 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $49 → $18 | $14.54 | +23.80% | 46 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,146 → $1,353 | $819.14 | +65.17% | 56 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 → $341 | $225.24 | +51.39% | 28 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $29 → $24 | $18.48 | +29.87% | 20 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.35 | - | 8 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.28 | - | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 | $72.09 | +108.07% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $62.23 | -11.62% | 35 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $424 → $454 | $369.06 | +23.02% | 45 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.45 | - | 19 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 | $255.56 | -11.29% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4799 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.76 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.03 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.21 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.53 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 | $87.71 | +7.17% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.50 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.80 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $342.00 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.59 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.00 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $3 | $4.85 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.91 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $684 → $565 | $790.74 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $6.58 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.18 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.00 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.13 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.52 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $232.65 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $156.19 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $9.82 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $137 → $132 | $31.32 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $9.18 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $17.10 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $45.95 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $100 | $499.74 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.000135 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $49.51 | n/a | 1 | Nov 17, 2010 |
Stoke Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $60
Current: $24.17
Upside: +148.24%
Alector
Oct 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.84
Upside: -
Genmab
Oct 5, 2026
Reiterated: Buy
Price Target: $43
Current: $37.00
Upside: +16.22%
Foghorn Therapeutics
Oct 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.86
Upside: -
Kailera Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $57
Current: $11.25
Upside: +406.67%
Zymeworks
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $25.03
Upside: +35.84%
Ionis Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $84
Current: $42.94
Upside: +95.62%
Amgen
Sep 22, 2026
Reiterated: Buy
Price Target: $452
Current: $432.49
Upside: +4.51%
Roivant Sciences
Sep 9, 2026
Rated: Buy
Price Target: $50 → $55
Current: $33.53
Upside: +64.03%
Ultragenyx Pharmaceutical
Sep 3, 2026
Rated: Buy
Price Target: $49 → $18
Current: $14.54
Upside: +23.80%
Aug 17, 2026
Reiterated: Buy
Price Target: $1,146 → $1,353
Current: $819.14
Upside: +65.17%
Aug 13, 2026
Reiterated: Buy
Price Target: $325 → $341
Current: $225.24
Upside: +51.39%
Aug 12, 2026
Rated: Hold
Price Target: $29 → $24
Current: $18.48
Upside: +29.87%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.35
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.28
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $150
Current: $72.09
Upside: +108.07%
Aug 5, 2026
Reiterated: Buy
Price Target: $55
Current: $62.23
Upside: -11.62%
Aug 5, 2026
Reiterated: Buy
Price Target: $424 → $454
Current: $369.06
Upside: +23.02%
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.45
Upside: -
May 18, 2026
Reiterated: Buy
Price Target: $227
Current: $255.56
Upside: -11.29%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4799
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.76
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.03
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.21
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.53
Upside: -
May 5, 2026
Reiterated: Hold
Price Target: $94
Current: $87.71
Upside: +7.17%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.50
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: -
Mar 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.80
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $342.00
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.59
Upside: n/a
Mar 11, 2024
Reiterated: Buy
Price Target: n/a
Current: $46.00
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $25 → $3
Current: $4.85
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $5.91
Upside: n/a
Feb 8, 2021
Reiterated: Hold
Price Target: $684 → $565
Current: $790.74
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $6.58
Upside: n/a
Aug 5, 2020
Reiterated: Buy
Price Target: n/a
Current: $2.18
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Dec 31, 2019
Reiterated: Hold
Price Target: n/a
Current: $3.13
Upside: n/a
Aug 12, 2019
Reiterated: Hold
Price Target: n/a
Current: $29.52
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $232.65
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $156.19
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $9.82
Upside: n/a
Feb 18, 2015
Reiterated: Hold
Price Target: $137 → $132
Current: $31.32
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $9.18
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $17.10
Upside: n/a
Jun 4, 2013
Reiterated: Hold
Price Target: $7 → $5
Current: $45.95
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $63 → $100
Current: $499.74
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.000135
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $49.51
Upside: n/a